PRGO vs HLN vs CHGG vs PBH vs CLAR

For growth investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger pick with 1. 1% revenue growth year-over-year, versus -39. 0% for Chegg, Inc. (CHGG). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 2x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Prestige Consumer Healthcare Inc.

(PBH) is the cheapest at 12. 2x versus Haleon plc at 18. 7x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Prestige Consumer Healthcare Inc. wins at 1. 28x versus Haleon plc's 2. 56x — a reasonable growth-adjusted valuation.

Over the past 5 years, Haleon plc (HLN) delivered a total return of +29.

0%, compared to -98. 6% for Chegg, Inc. (CHGG). Over 10 years, the gap is even starker: HLN returned +29. 0% versus PRGO's -77. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Haleon plc (HLN) is the lower-risk stock at 0.

03β versus Chegg, Inc. 's 2. 83β — meaning CHGG is approximately 9746% more volatile than HLN relative to the S&P 500. On balance sheet safety, Clarus Corporation (CLAR) carries a lower debt/equity ratio of 6% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Prestige Consumer Healthcare Inc.

(PBH) is pulling ahead at 1. 1% versus -39. 0% for Chegg, Inc. (CHGG). On earnings-per-share growth, the picture is similar: Chegg, Inc. grew EPS 88. 1% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, PBH leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus -16. 8% for CHGG. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Prestige Consumer Healthcare Inc. (PBH) is the more undervalued stock at a PEG of 1. 28x versus Haleon plc's 2. 56x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Perrigo Company plc (PRGO) trades at 5. 5x forward P/E versus 21. 6x for Haleon plc — 16. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHGG: 2522. 4% to $30. 42.

In this comparison, PRGO (9.

8% yield), CLAR (3. 3% yield), HLN (2. 0% yield) pay a dividend. CHGG, PBH do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Haleon plc (HLN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

03), 2. 0% yield). Chegg, Inc. (CHGG) carries a higher beta of 2. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HLN: +29. 0%, CHGG: -73. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PRGO (Healthcare) and HLN (Healthcare) and CHGG (Consumer Defensive) and PBH (Healthcare) and CLAR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PRGO is a small-cap income-oriented stock; HLN is a mid-cap quality compounder stock; CHGG is a small-cap quality compounder stock; PBH is a small-cap deep-value stock; CLAR is a small-cap income-oriented stock. PRGO, HLN, CLAR pay a dividend while CHGG, PBH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.